amyloidP-IN-1有利于在疾病或功能失调的治疗中消耗血清淀粉样蛋白P组件(SAP)，包括淀粉样变,阿尔茨海默病，2型糖尿病和关节炎。
| Cas No. | 1819986-22-5 |
| Canonical SMILES | O=C(OCOC(OC1CCOCC1)=O)[C@H]2CCCN2C(CCCCC(N3[C@@H](C(OCOC(OC4CCOCC4)=O)=O)CCC3)=O)=O |
| 分子式 | C30H44N2O14 |
| 分子量 | 656.68 |
| 溶解度 | DMSO : ≥ 34 mg/mL (51.78 mM) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes mellitus and osteoarthritis. [1]. PCT Int. Appl. (2015), WO 2015165833 A1 20151105. [2]. U.S. Pat. Appl. Publ. (2016), US 20160081983 A1 20160324. |
